Abbonarsi

Double-balloon enteroscopy–facilitated cyanoacrylate-injection endotherapy of small-bowel varices: an international experience from 2 European tertiary centers (with videos) - 27/07/19

Doi : 10.1016/j.gie.2019.03.1171 
Edward J. Despott, MD, FEBGH, FRCP, MD(Res) 1, , Andrea May, MD, PhD 2, Nikolaos Lazaridis, MD, PhD 1, Erasmia Vlachou, MD, FEBGH 1, 3, Nikolaos Koukias, MD 1, David Patch, MBBS, FRCP 1, Katie Planche, MBBS, FRCR 4, Yoshikazu Hayashi, MD, PhD 1, 5, Alberto Murino, MD 1
1 Royal Free Unit for Endoscopy, The Royal Free Hospital and University College London Institute for Liver and Digestive Health, Hampstead, London, UK 
4 Department of Radiology, The Royal Free Hospital and University College London Institute for Liver and Digestive Health, Hampstead, London, UK 
2 Department of Gastroenterology, Sana Klinikum Offenbach GmbH and University of Mainz, Germany 
3 NIMTS Army Veterans Hospital, Athens, Greece 
5 Department of Medicine, Division of Gastroenterology, Jichi Medical University, Shimotsuke, Japan 

Reprint requests: Edward J. Despott, The Royal Free Hospital and University College London (UCL) Institute for Liver and Digestive Health, London NW3 2QG, United Kingdom.The Royal Free Hospital and University College London (UCL) Institute for Liver and Digestive HealthLondonNW3 2QGUnited Kingdom

Abstract

Background and Aims

Small-bowel varices (SBVs) are an uncommon consequence of portal hypertension. Radiologic intervention is usually considered for first-line management. When radiologic intervention is not possible, management options become very limited. The aim of this study was to evaluate the usefulness of double-balloon enteroscopy (DBE)-facilitated cyanoacrylate-injection endotherapy of SBVs.

Methods

This was a retrospective review of DBE-facilitated cyanoacrylate-injection endotherapy of SBVs (December 2015 to October 2016).

Results

Ten DBEs were performed in 6 patients (4 women; median age, 68.5 years). No radiologic or surgical options were deemed feasible. Thirteen nests of SBVs were identified and injected with cyanoacrylate glue without hemorrhagic or embolic adverse events. At the 30-day follow-up after therapy, only 1 patient had experienced a mild recurrence of mid-gut bleeding; this was managed conservatively. One patient presented with acute GI bleeding 7 months later, and a repeat DBE with cyanoacrylate-injection endotherapy was successfully performed. One patient succumbed to his underlying advanced cholangiocarcinoma after 2 months. The remaining patients had a median follow-up of 12 months without any recurrent GI bleeding.

Conclusions

DBE-facilitated cyanoacrylate-injection endotherapy of SBVs appears to be a safe and effective option when other first-line options are not feasible.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : DBE, SBVs


Mappa


 DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: E. J. Despott: Research support recipient from Aquilant Medical and Fujifilm; education research recipient from Olympus and Pentax Medical. A. May: Research support recipient from Fujifilm, Olympus, and Interscope. Y. Hayashi: Honoraria from Fujifilm. A. Murino: Research support recipient from Olympus, Pentax, and Fujifilm. All other authors disclosed no financial relationships relevant to this publication.


Crown Copyright © 2019  Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 90 - N° 2

P. 302-306 - agosto 2019 Ritorno al numero
Articolo precedente Articolo precedente
  • Continuing Medical Education Exam: August 2019
  • Karthik Ravi, William Ross, Ara Sahakian, Brian Weston, Prasad G. Iyer, Amit Rastogi, Michael B. Wallace
| Articolo seguente Articolo seguente
  • Sequential infection by herpes simplex virus, Candida species, and Cytomegalovirus species in esophagus
  • Takuto Yoshioka, Munehiro Ikeda, Naoki Kanda

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.